Gilead Sciences, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, CA

Insiders trading volume in the past year

Gilead Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel P. O'Day Chairman & CEO, Director $86.4M -$8.06M -8.53% Nov 28, 2025
Andrew D. Dickinson Chief Financial Officer $23.9M -$33.8M -58.6% Nov 17, 2025
Johanna Mercier Chief Commercial Officer $18.1M -$11.2M -38.2% Nov 17, 2025
Merdad Parsey Chief Medical Officer $13.9M Dec 10, 2024
Deborah H. Telman EVP, Corporate Affairs & GC $9.14M -$6.59M -41.9% Nov 12, 2025
Olsen Per Wold Director $8.75M May 6, 2021
Sandra Patterson SVP, Controllership $6.81M Mar 10, 2025
Dietmar Berger Chief Medical Officer $5.99M Mar 10, 2025
Diane E. Wilfong Interim Corp Controller & CAO $5.33M Sep 10, 2025
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel $4.17M Jun 10, 2022
Richard James Whitley Director $3.15M May 6, 2021
Jacqueline K. Barton Director $2.7M May 7, 2025
Harish Manwani Director $1.39M May 7, 2025
Javier Rodriguez Director $1.27M May 7, 2025
Anthony Welters Director $1.22M May 7, 2025
Jeffrey Bluestone Director $1.12M -$1.17M -51.3% Nov 28, 2025
Sandra Horning Director $1.04M May 7, 2025
Ted W. Love Director $450K May 7, 2025
Kelly A. Kramer Director $170K -$713K -80.7% Nov 26, 2025
Kevin E. Lofton Director Mar 28, 2024
Erin Burkhart SVP, Controllership Sep 22, 2025

Recent Insider Transactions by Companies or Individuals for Gilead Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.